From smartphone apps that use facial recognition to classify facial features associated with certain congenital and neurodevelopmental disorders, to predicting cancer response to immunotherapy or speeding a rare disease diagnosis, to assessing the need for treatment in arthritis patients … artificial intelligence and machine learning are being put to use in ways that seem almost science fiction-like sometimes. For people living with rare diseases, however, these innovative uses of the technology could be game changing.
Once again, we’ve worked with our friends at PharmaPhorum to spotlight the potential benefits that artificial intelligence and machine learning can bring to the healthcare and pharma worlds. Check it out here.